MRC1 and Lynch syndrome: A study performed by Shirts et al. (2018) demonstrated that tumor mutations in the MMR genes can support both pathogenic and benign variant classification by identifying somatic driver mutations compared with passenger mutations in patients with unexplained dMMR (i.e., suspected Lynch syndrome or Lynch-like syndrome) [54].